Javascript must be enabled to continue!
Mutations dislocate caspase‐12 from the endoplasmatic reticulum to the cytosol
View through CrossRef
Mouse AKR‐2B cells express two forms of caspase‐12: the full‐length form coding for a protein of 47.8 kDa and a new splice variant of 40.2 kDa which is devoid of the CARD domain. In addition, three point mutations were disclosed: I/L‐15, E/D‐46 and P/L‐105. A major portion of the two protein variants was found in the cytosol. Immunofluorescence studies showed an even distribution of caspase‐12 within the cell, indicative for a cytoplasmatic localization. Transfection of AKR‐2B cells with wild‐type caspase‐12 showed a colocalization of this protein with the endoplasmic reticulum (ER). Unlike mouse embryonal fibroblasts (MEF) which contain wild‐type caspase‐12, AKR‐2B cells were largely resistant against treatment with the endoplasmatic reticulum stressing reagents brefeldin and tunicamycin. In AKR‐2B cells, cytoplasmatic caspase‐12 is bound to high molecular weight complexes of >1000 kDa [Cell Death Differ. 9 (2001) 125] and serum depletion leads to cleavage and detachment of caspase‐12 from this high molecular weight complex. Cleavage of caspase‐12 and ‐3 occurred almost simultaneously reaching a maximum 3–5 h after serum deprivation at which time also maximum apoptosis is found. Analysis of caspase‐12 cleavage in vitro in comparison with fragmentation in vivo suggests that during death in AKR‐2B cells induced by starvation, cleavage was brought about by caspase‐3 at positions D24 and D94. Thus, mutated caspase‐12 is differently integrated in signaling pathways of cell death and has lost its function as initiator caspase upon ER‐stress. Instead, it is turned into a substrate of effector caspases. The implication of these findings in the pathological phenotype of ARK‐2B mice is discussed.
Title: Mutations dislocate caspase‐12 from the endoplasmatic reticulum to the cytosol
Description:
Mouse AKR‐2B cells express two forms of caspase‐12: the full‐length form coding for a protein of 47.
8 kDa and a new splice variant of 40.
2 kDa which is devoid of the CARD domain.
In addition, three point mutations were disclosed: I/L‐15, E/D‐46 and P/L‐105.
A major portion of the two protein variants was found in the cytosol.
Immunofluorescence studies showed an even distribution of caspase‐12 within the cell, indicative for a cytoplasmatic localization.
Transfection of AKR‐2B cells with wild‐type caspase‐12 showed a colocalization of this protein with the endoplasmic reticulum (ER).
Unlike mouse embryonal fibroblasts (MEF) which contain wild‐type caspase‐12, AKR‐2B cells were largely resistant against treatment with the endoplasmatic reticulum stressing reagents brefeldin and tunicamycin.
In AKR‐2B cells, cytoplasmatic caspase‐12 is bound to high molecular weight complexes of >1000 kDa [Cell Death Differ.
9 (2001) 125] and serum depletion leads to cleavage and detachment of caspase‐12 from this high molecular weight complex.
Cleavage of caspase‐12 and ‐3 occurred almost simultaneously reaching a maximum 3–5 h after serum deprivation at which time also maximum apoptosis is found.
Analysis of caspase‐12 cleavage in vitro in comparison with fragmentation in vivo suggests that during death in AKR‐2B cells induced by starvation, cleavage was brought about by caspase‐3 at positions D24 and D94.
Thus, mutated caspase‐12 is differently integrated in signaling pathways of cell death and has lost its function as initiator caspase upon ER‐stress.
Instead, it is turned into a substrate of effector caspases.
The implication of these findings in the pathological phenotype of ARK‐2B mice is discussed.
Related Results
Abstract 2940: Statin induced apoptosis in human melanoma cells is prevented by inhibition of caspase 2 and translational activity.
Abstract 2940: Statin induced apoptosis in human melanoma cells is prevented by inhibition of caspase 2 and translational activity.
Abstract
Background: Statins may trigger apoptosis in tumour cells in vitro and, particularly, melanoma cells are susceptible to statin induced apoptosis. Lipophilic...
Abstract 1543: Caspase-10 suppresses tumorigenesis by targeting ATP-citrate lyase
Abstract 1543: Caspase-10 suppresses tumorigenesis by targeting ATP-citrate lyase
Abstract
p53 fosters metabolic reprogramming, which restricts metabolic adaptation of tumor cells under energy stress conditions. However, modulation and directional...
Dynamics of Mutations in Patients with ET Treated with Imetelstat
Dynamics of Mutations in Patients with ET Treated with Imetelstat
Abstract
Background: Imetelstat, a first in class specific telomerase inhibitor, induced hematologic responses in all patients (pts) with essential thrombocythemia (...
High Resolution Melt Analysis for Rapid and Cost-Effective Screening of TP53 Mutations in Patients with Myeloid Malignancies
High Resolution Melt Analysis for Rapid and Cost-Effective Screening of TP53 Mutations in Patients with Myeloid Malignancies
Abstract
Background
Recent reports have highlighted an adverse impact of TP53 mutations on the prognosis of patients with myeloid malignancies. TP53 m...
Clinical and Biological Implications of CUX1 Mutations in Myeloid Neoplasms
Clinical and Biological Implications of CUX1 Mutations in Myeloid Neoplasms
Abstract
Recurrent somatic mutations of CUX1 are described in myeloid neoplasms. CUX1 is located at chromosome 7q22.1; -7/del(7q) involving CUX1 locus are common abn...
Small Subclones Harboring NOTCH1, SF3B1 or BIRC3 Mutations Are Clinically Irrelevant in Chronic Lymphocytic Leukemia
Small Subclones Harboring NOTCH1, SF3B1 or BIRC3 Mutations Are Clinically Irrelevant in Chronic Lymphocytic Leukemia
Abstract
Introduction. Ultra-deep next generation sequencing (NGS) allows sensitive detection of mutations and estimation of their clonal abundance in tumor cell pop...
Analysis of Molecular Minimal Residual Disease in Patients with Acute Leukemia during Complete Remission
Analysis of Molecular Minimal Residual Disease in Patients with Acute Leukemia during Complete Remission
Abstract
Introduction: Acute leukemia is a group of clonal heterogeneous diseases with high recurrence rate. The monitoring of minimal residual disease (MRD) after t...
Inhibition of cathepsin B by caspase-3 inhibitors blocks programmed cell death in Arabidopsis
Inhibition of cathepsin B by caspase-3 inhibitors blocks programmed cell death in Arabidopsis
Abstract
Programmed cell death (PCD) is used by plants for development and survival to biotic and abiotic stresses. The role of caspases in PCD is well established in ani...

